Plant Comparison
Blue gum eucalyptus vs Oregon Grape
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Blue gum eucalyptus and Oregon Grape: they share 5 indicated uses (arthritis / joint pain, infection (general), inflammation (general), …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Blue gum eucalyptus | Oregon Grape | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 2/10 | 7/10 | Stronger for Oregon Grape |
| Infection (general) | 2/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 2/10 | 7/10 | Stronger for Oregon Grape |
| Skin irritation | 2/10 | 8/10 | Stronger for Oregon Grape |
| Wounds | 2/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Leaf essential oil dominated by 1,8-cineole (eucalyptol, typically 70%+), the principal compound responsible for the plant's antimicrobial, anti-inflammatory and expectorant/decongestant activity.
Pharmacological Actions
Anti-inflammatory and antiproliferative (slows the skin-cell overgrowth of psoriasis)
Anti-inflammatory and antiproliferative (slows the skin-cell overgrowth of psoriasis)
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from immunomodulator action
inferred from antifungal action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anticancer action
Topical for atopic dermatitis (eczema) and skin irritation
Antimicrobial (berberine) - supports skin and mucosal infection
inferred from anti-inflammatory action
Anti-inflammatory and antiproliferative (slows the skin-cell overgrowth of psoriasis); Topical treatment of mild-to-moderate psoriasis (reduces plaque severity) - a double-blind, placebo-controlled RCT showed significant improvement in PASI and quality-of-life scores
Topical for atopic dermatitis (eczema) and skin irritation
Safety, Cautions & Contraindications
Eucalyptus globulus essential oil is highly concentrated and rich in the monoterpene 1,8-cineole; it should never be applied undiluted to the skin or ingested outside of standardized pharmaceutical preparations. Improper use can cause irritation, nausea, dizziness, or neurological symptoms, and inhalation at high concentrations may provoke respiratory distress, particularly in infants, young children, or individuals with asthma or other airway sensitivities. For this reason, essential oil use is generally discouraged in children and during pregnancy unless under professional guidance. Preparations such as leaf-infused oils or external applications using whole plant material are considerably milder, but they should still be used with care and an understanding that different preparation methods carry different levels of risk.
Duke (2002) provides clinical evidence (score 2) for eucalyptus as an expectorant and topical hyperemic (rubefacient), consistent with Commission E approval. Clinical evidence also supports its use in asthma, bronchitis, and catarrh. The essential oil (primarily 1,8-cineole) is the active constituent. Therapeutic use as steam inhalation is well-established. Internal use of the essential oil at high doses is contraindicated due to toxicity; even small amounts (3.5 ml) can be fatal in children. Contraindicated for inflammatory diseases of the gastrointestinal tract or bile ducts (Duke, 2002).
Avoid internal use in pregnancy and breastfeeding: like goldenseal, the berberine it contains can cross the placenta and into milk and worsen newborn jaundice (kernicterus risk).
External Ids
Botanical Description
Large, fast-growing evergreen tree with distinctive two-stage leaves: rounded, silvery-blue juvenile leaves borne in opposite pairs, giving way to narrow, sickle-shaped, aromatic, dark green mature leaves as the tree ages. Small, cream-white, fluffy flowers with numerous stamens are borne singly or in small clusters, followed by a woody, cup-shaped seed capsule ('gum nut').[12]
Evergreen shrub, 0.5-2 m tall, spreading by underground rhizomes to form thickets. The pinnate leaves resemble holly, with 5-9 glossy, dark green, spiny-toothed leaflets that often turn bronze-red in winter. Small, bright yellow, six-petalled flowers are borne in dense, upright terminal racemes in early spring, followed by clusters of blue-black, grape-like berries with a waxy bloom. The wood and inner bark of the stem and root are bright yellow when cut, owing to their high content of berberine-type alkaloids.
Habitat
Native to south-eastern Australia and Tasmania; widely planted worldwide in warm-temperate and Mediterranean climates for timber, essential oil production and as an ornamental/windbreak tree.
Native to the Pacific Northwest of North America, growing in coniferous woodland understorey, forest margins and rocky slopes; widely introduced and naturalised as an ornamental and hedging shrub in temperate regions elsewhere.
Harvesting
Mature leaves are picked or pruned year-round and used fresh, dried, or steam-distilled for essential oil, which is the main commercial and medicinal form.
The root and root bark, the medicinal parts, are dug from established plants - traditionally in autumn - and dried. Because wild populations are slow-growing, cultivated or nursery-sourced material is preferred over wild-harvesting.
Traditional Uses
Eucalyptus leaf has a long Australian Aboriginal and, after global spread, worldwide tradition as a respiratory remedy - inhaled as steam or applied as chest rubs for colds, coughs, bronchitis and catarrh - and as a topical antiseptic and rubefacient for minor wounds and muscular aches.[12]
Oregon grape root has a traditional Native American and Eclectic-medicine history as a bitter tonic and alterative (blood-purifying) remedy and for skin conditions. Its main modern use, supported by clinical trials, is topical application of a standardised bark extract for mild-to-moderate psoriasis and atopic dermatitis (eczema), where its berberine-type alkaloids give anti-inflammatory and antiproliferative effects on skin cells.[1, 11, 12]
Preparations
A few drops of essential oil, or fresh/dried leaf, added to hot water and the vapour inhaled for respiratory congestion; the classic and best-established use.
Diluted essential oil in a carrier oil or standardised ointment applied to the chest and back for coughs and colds.
Comminuted dried leaf infused in 150 ml boiling water, 1.5-3 g up to four times daily (daily dose 4.5-12 g) for oral use per the EU herbal monograph. Educational reference only, not a prescription.
Dosage
The EU herbal monograph on eucalyptus LEAF gives, for inhalation, 3 g of the comminuted leaf in boiling water up to 3 times daily (daily dose 3-9 g), and for oral use 1.5-3 g in 150 mL as an infusion up to 4 times daily (daily dose 4.5-12 g), in adolescents, adults and elderly. Use is CONTRAINDICATED in children under 30 months, and not recommended under 12 years. The essential oil is a separate herbal substance with its own monograph and its own posology - it is never taken internally or applied undiluted to skin on the strength of these leaf figures. Educational reference only, not a prescription.
References
Lookalikes Review
References & Sources
- Čmiková, N., Galovičová, L., Schwarzová, M., Vukic, M.D. et al (2023) 'Chemical Composition and Biological Activities of Eucalyptus globulus Essential Oil', Plants (Basel), 12(5), pp. 1076. doi:10.3390/plants12051076 Preclinical
https://doi.org/10.3390/plants12051076 - Elangovan, S. and Mudgil, P (2023) 'Antibacterial Properties of Eucalyptus globulus Essential Oil against MRSA: A Systematic Review', Antibiotics (Basel), 12(3), pp. 474. doi:10.3390/antibiotics12030474 Meta-analysis / review
https://doi.org/10.3390/antibiotics12030474 - Zonfrillo, M., Andreola, F., Krasnowska, E.K., Sferrazza, G. et al (2022) 'Essential Oil from Eucalyptus globulus (Labill.) Activates Complement Receptor-Mediated Phagocytosis and Stimulates Podosome Formation in Human Monocyte-Derived Macrophages', Molecules, 27(11), pp. 3488. doi:10.3390/molecules27113488 Preclinical
https://doi.org/10.3390/molecules27113488 - Arooj, B., Asghar, S., Saleem, M., Khalid, S.H., Asif, M., Chohan, T., Khan, I.U., Zubair, H.M. and Yaseen, H.S (2023) 'Anti-inflammatory mechanisms of eucalyptol rich Eucalyptus globulus essential oil alone and in combination with flurbiprofen', Inflammopharmacology, 31(4), pp. 1849-1862. doi:10.1007/s10787-023-01237-6 Preclinical
https://doi.org/10.1007/s10787-023-01237-6 - Assaggaf, H.M., Naceiri Mrabti, H., Rajab, B.S., Attar, A.A., Hamed, M., Sheikh, R.A., Omari, N.E., Menyiy, N.E., Belmehdi, O., Mahmud, S., Alshahrani, M.M., Park, M.N., Kim, B., Zengin, G. and Bouyahya, A (2022) 'Singular and Combined Effects of Essential Oil and Honey of Eucalyptus globulus on Anti-Inflammatory, Antioxidant, Dermatoprotective, and Antimicrobial Properties: In Vitro and In Vivo Findings', Molecules, 27(16), pp. 5121. doi:10.3390/molecules27165121 Preclinical
https://doi.org/10.3390/molecules27165121 - Mulyaningsih, S., Sporer, F., Zimmermann, S., Reichling, J. and Wink, M (2010) 'Synergistic properties of the terpenoids aromadendrene and 1,8-cineole from the essential oil of Eucalyptus globulus against antibiotic-susceptible and antibiotic-resistant pathogens', Phytomedicine, 17(13), pp. 1061-1066. doi:10.1016/j.phymed.2010.06.018 Preclinical
https://doi.org/10.1016/j.phymed.2010.06.018 - Luis, A., Neiva, D., Pereira, H., Gominho, J., Domingues, F. and Duarte, A.P (2014) 'Stumps of Eucalyptus globulus as a source of antioxidant and antimicrobial polyphenols', Molecules, 19(10), pp. 16428-16446. doi:10.3390/molecules191016428 Preclinical
https://doi.org/10.3390/molecules191016428 - Merghni, A., Noumi, E., Hadded, O., Dridi, N., Panwar, H., Ceylan, O., Mastouri, M. and Snoussi, M (2018) 'Assessment of the antibiofilm and antiquorum sensing activities of Eucalyptus globulus essential oil and its main component 1,8-cineole against methicillin-resistant Staphylococcus aureus strains', Microbial Pathogenesis, 118, pp. 74-80. doi:10.1016/j.micpath.2018.03.006 Preclinical
https://doi.org/10.1016/j.micpath.2018.03.006 - Mousa, A.A., Elweza, A.E., Elbaz, H.T., Tahoun, E.A.E., Shoghy, K.M., Elsayed, I. and Hassan, E.B (2019) 'Eucalyptus Globulus protects against diclofenac sodium induced hepatorenal and testicular toxicity in male rats', Journal of Traditional and Complementary Medicine, 10(6), pp. 521-528. doi:10.1016/j.jtcme.2019.11.002 Preclinical
https://doi.org/10.1016/j.jtcme.2019.11.002 - Mota, V.S., Turrini, R.N.T. and Poveda, V.B (2015) 'Antimicrobial activity of Eucalyptus globulus oil, xylitol and papain: a pilot study', Revista da Escola de Enfermagem da USP, 49(2), pp. 216-220. doi:10.1590/S0080-623420150000200005 Preclinical
https://doi.org/10.1590/S0080-623420150000200005 - Nguyen, H.T.T., Miyamoto, A., Nguyen, H.T., Pham, H.T., Hoang, H.T., Tong, N.T.M., Truong, L.T.N. and Nguyen, H.T.T (2023) 'Antibacterial effects of essential oils from Cinnamomum cassia bark and Eucalyptus globulus leaves - the involvements of major constituents', PLoS One, 18(7), pp. e0288787. doi:10.1371/journal.pone.0288787 Preclinical
https://doi.org/10.1371/journal.pone.0288787 - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - European Medicines Agency (HMPC) (2013) 'Community herbal monograph on Eucalyptus globulus Labill., folium'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-eucalyptus-globulus-labill-folium_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-eucalyptus-globulus-labill-folium_en.pdf - Sadlon, A.E. and Lamson, D.W (2010) 'Immune-modifying and antimicrobial effects of Eucalyptus oil and simple inhalation devices', 15(1), pp. 33--47. Preclinical
https://scholar.google.com/scholar?q=Immune-modifying%20and%20antimicrobial%20effects%20of%20Eucalyptus%20oil%20and%20simple%20inhalation%20devices - World Health Organization (2002) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
- Gulliver, W.P. and Donsky, H.J (2005) 'A report on three recent clinical trials using Mahonia aquifolium 10% topical cream and a review of the worldwide clinical experience with Mahonia aquifolium for the treatment of plaque psoriasis', American Journal of Therapeutics, 12(5), pp. 398-406. doi:10.1097/01.mjt.0000174350.82270.da Clinical study
https://doi.org/10.1097/01.mjt.0000174350.82270.da - Cernakova, M. and Kostalova, D (2002) 'Antimicrobial activity of berberine--a constituent of Mahonia aquifolium', Folia Microbiologica, 47(4), pp. 375-378. doi:10.1007/BF02818693 Preclinical
https://doi.org/10.1007/BF02818693 - Damjanovic, A., Kolundzija, B., Matic, I.Z., Krivokuca, A. and others (2020) 'Mahonia aquifolium Extracts Promote Doxorubicin Effects against Lung Adenocarcinoma Cells In Vitro', Molecules, 25(22), pp. 5233. doi:10.3390/molecules25225233 Preclinical
https://doi.org/10.3390/molecules25225233 - Cernakova, M., Kostalova, D., Kettmann, V., Plodova, M. and others (2002) 'Potential antimutagenic activity of berberine, a constituent of Mahonia aquifolium', BMC Complementary and Alternative Medicine, 2, pp. 2. doi:10.1186/1472-6882-2-2 Preclinical
https://doi.org/10.1186/1472-6882-2-2 - Slobodnikova, L., Kostalova, D., Labudova, D., Kotulova, D. and Kettmann, V (2004) 'Antimicrobial activity of Mahonia aquifolium crude extract and its major isolated alkaloids', Phytotherapy Research, 18(8), pp. 674-676. doi:10.1002/ptr.1517 Preclinical
https://doi.org/10.1002/ptr.1517 - Godjevac, D., Damjanovic, A., Stanojkovic, T.P., Andjelkovic, B. and Zdunic, G (2018) 'Identification of cytotoxic metabolites from Mahonia aquifolium using 1H NMR-based metabolomics approach', Journal of Pharmaceutical and Biomedical Analysis, 150, pp. 9-14. doi:10.1016/j.jpba.2017.11.075 Preclinical
https://doi.org/10.1016/j.jpba.2017.11.075 - Muller, K. and Ziereis, K (1994) 'The antipsoriatic Mahonia aquifolium and its active constituents; I. Pro- and antioxidant properties and inhibition of 5-lipoxygenase', Planta Medica, 60(5), pp. 421-424. doi:10.1055/s-2006-959523 Preclinical
https://doi.org/10.1055/s-2006-959523 - Rohrer, U., Kunz, E.M.K., Lenkeit, K., Schaffner, W. and Meyer, J (2007) 'Antimicrobial activity of Mahonia aquifolium and two of its alkaloids against oral bacteria', Schweizer Monatsschrift fur Zahnmedizin, 117(11), pp. 1126-1131. Preclinical
https://scholar.google.com/scholar?q=Antimicrobial%20activity%20of%20Mahonia%20aquifolium%20and%20two%20of%20its%20alkaloids%20against%20oral%20bacteria - Vollekova, A., Kostalova, D., Kettmann, V. and Toth, J (2003) 'Antifungal activity of Mahonia aquifolium extract and its major protoberberine alkaloids', Phytotherapy Research, 17(7), pp. 834-837. doi:10.1002/ptr.1256 Preclinical
https://doi.org/10.1002/ptr.1256 - Hajnicka, V., Kostalova, D., Svecova, D., Sochorova, R. and others (2002) 'Effect of Mahonia aquifolium active compounds on interleukin-8 production in the human monocytic cell line THP-1', Planta Medica, 68(3), pp. 266-268. doi:10.1055/s-2002-23126 Preclinical
https://doi.org/10.1055/s-2002-23126 - Gulliver, W.P. and colleagues (2018) 'Review of the Efficacy and Safety of Topical Mahonia aquifolium for the Treatment of Psoriasis and Atopic Dermatitis', Journal of Clinical and Aesthetic Dermatology. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334833/ Meta-analysis / review
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334833/ - Herbal Reality (n.d.) 'Oregon Grape Root (Berberis aquifolium): Benefits, Uses, Safety'. Available at: https://www.herbalreality.com/herb/oregon-grape/ Traditional / reference
https://www.herbalreality.com/herb/oregon-grape/ - Bernstein, S., Donsky, H., Gulliver, W., Hamilton, D., Nobel, S. and Norman, R (2006) 'Treatment of mild to moderate psoriasis with Relieva, a Mahonia aquifolium extract - a double-blind, placebo-controlled study', American Journal of Therapeutics, 13(2), pp. 121--126. doi:10.1097/00045391-200603000-00007 Randomized trial
https://doi.org/10.1097/00045391-200603000-00007
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.